Analyst on US Coloplast contract: Important contract – volumes will probably increase
It's incredibly important for Coloplast that the medtech company has landed a deal to sell ostomy products by way of the largest group purchasing organization in the US, Vizient, according to senior equity analyst. He expects the new contract will lead to increased volumes in the long term.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Read this article for free
Register with your E-mail. No credit card required.